FABRAZYME (agalsidase beta) is an infusion used to replace the missing enzyme in patients with Fabry disease, an inherited disorder caused by the deficiency of an enzyme called alpha-galactosidase A or alpha-GAL.


Learn more about Metro Infusion Center's unique, compassionate approach to care and why patients continue to choose Metro Infusion Center for all their infusion needs.


INFUSION THERAPIES PROVIDED


ACTEMRA


ANTIBIOTICS


BENLYSTA


CIMZIA


ENTYVIO


FABRAZYME


IVIG


IV STEROIDS


NULOJIX


ORENCIA


PROLIA


REMICADE


RITUXAN


SIMPONI ARIA


TYSABRI


XOLAIR


INFUSION THERAPIES: FABRAZYME

Our physicians are amongst the most sought-after practitioners for the challenging infusion cases.

This includes helping patients in need of enzyme-replacement therapy and other rare conditions.

Fabrazyme (agalsidase beta) is just one of these specific therapies and is used to treat patients with fabry disease. It works by lowering the amount of globotriaosylceramide (gl-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.

CALL 877.448.3627 FOR MORE INFORMATION OR TO SCHEDULE AN APPOINTMENT.